Works by Kazuyoshi Saito

Results: 170
    1
    2
    3
    4
    5
    6
    7
    8
    9

    An open-label, randomized controlled trial of sulfamethoxazole–trimethoprim for Pneumocystis prophylaxis: results of 52-week follow-up.

    Published in:
    Rheumatology Advances in Practice, 2020, v. 4, n. 2, p. 1, doi. 10.1093/rap/rkaa029
    By:
    • Utsunomiya, Masako;
    • Dobashi, Hiroaki;
    • Odani, Toshio;
    • Saito, Kazuyoshi;
    • Yokogawa, Naoto;
    • Nagasaka, Kenji;
    • Takenaka, Kenchi;
    • Soejima, Makoto;
    • Sugihara, Takahiko;
    • Hagiyama, Hiroyuki;
    • Hirata, Shinya;
    • Matsui, Kazuo;
    • Nonomura, Yoshinori;
    • Kondo, Masahiro;
    • Suzuki, Fumihito;
    • Nawata, Yasushi;
    • Tomita, Makoto;
    • Kihara, Mari;
    • Yokoyama-Kokuryo, Waka;
    • Hirano, Fumio
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16

    The REAL database reveals no significant risk of serious infection during treatment with a methotrexate dose of more than 8 mg/week in patients with rheumatoid arthritis.

    Published in:
    Modern Rheumatology, 2011, v. 21, n. 4, p. 444, doi. 10.3109/s10165-011-0421-z
    By:
    • Sakai, Ryoko;
    • Komano, Yukiko;
    • Tanaka, Michi;
    • Nanki, Toshihiro;
    • Koike, Ryuji;
    • Nakajima, Atsuo;
    • Atsumi, Tatsuya;
    • Yasuda, Shinsuke;
    • Tanaka, Yoshiya;
    • Saito, Kazuyoshi;
    • Tohma, Shigeto;
    • Fujii, Takao;
    • Ihata, Atsushi;
    • Tamura, Naoto;
    • Kawakami, Atsushi;
    • Sugihara, Takahiko;
    • Ito, Satoshi;
    • Miyasaka, Nobuyuki;
    • Harigai, Masayoshi
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23

    Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year outcome of joint destruction (RECONFIRM-2J).

    Published in:
    Modern Rheumatology, 2008, v. 18, n. 5, p. 447, doi. 10.3109/s10165-008-0077-5
    By:
    • Takeuchi, Tsutomu;
    • Yamanaka, Hisashi;
    • Inoue, Eisuke;
    • Nagasawa, Hayato;
    • Nawata, Masao;
    • Ikari, Katsunori;
    • Saito, Kazuyoshi;
    • Sekiguchi, Naoya;
    • Sato, Eri;
    • Kameda, Hideto;
    • Iwata, Shigeru;
    • Mochizuki, Takeshi;
    • Amano, Kouichi;
    • Tanaka, Yoshiya
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    Optimal regimens of sulfamethoxazoletrimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases: results from a non-blinded, randomized controlled trial.

    Published in:
    Arthritis Research & Therapy, 2017, v. 19, p. 1, doi. 10.1186/s13075-016-1206-8
    By:
    • Masako Utsunomiya;
    • Hiroaki Dobashi;
    • Toshio Odani;
    • Kazuyoshi Saito;
    • Naoto Yokogawa;
    • Kenji Nagasaka;
    • Kenchi Takenaka;
    • Makoto Soejima;
    • Takahiko Sugihara;
    • Hiroyuki Hagiyama;
    • Shinya Hirata;
    • Kazuo Matsui;
    • Yoshinori Nonomura;
    • Masahiro Kondo;
    • Fumihito Suzuki;
    • Makoto Tomita;
    • Mari Kihara;
    • Waka Yokoyama;
    • Fumio Hirano;
    • Hayato Yamazaki
    Publication type:
    Article
    37

    Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry.

    Published in:
    Arthritis Research & Therapy, 2015, v. 17, n. 1, p. 1, doi. 10.1186/s13075-015-0583-8
    By:
    • Ryoko Sakai;
    • Soo-Kyung Cho;
    • Toshihiro Nanki;
    • Kaori Watanabe;
    • Hayato Yamazaki;
    • Michi Tanaka;
    • Ryuji Koike;
    • Yoshiya Tanaka;
    • Kazuyoshi Saito;
    • Shintaro Hirata;
    • Koichi Amano;
    • Hayato Nagasawa;
    • Takayuki Sumida;
    • Taichi Hayashi;
    • Takahiko Sugihara;
    • Hiroaki Dobashi;
    • Shinsuke Yasuda;
    • Tetsuji Sawada;
    • Kazuhiko Ezawa;
    • Atsuhisa Ueda
    Publication type:
    Article
    38
    39
    40
    41
    42

    Analysis of bone metabolism during early stage and clinical benefits of early intervention with alendronate in patients with systemic rheumatic diseases treated with high-dose glucocorticoid: Early DIagnosis and Treatment of OsteopoRosis in Japan (EDITOR-J) study.

    Published in:
    2016
    By:
    • Tanaka, Yoshiya;
    • Mori, Hiroko;
    • Aoki, Takatoshi;
    • Atsumi, Tatsuya;
    • Kawahito, Yutaka;
    • Nakayama, Hisanori;
    • Tohma, Shigeto;
    • Yamanishi, Yuji;
    • Hasegawa, Hitoshi;
    • Tanimura, Kazuhide;
    • Negoro, Nobuo;
    • Ueki, Yukitaka;
    • Kawakami, Atsushi;
    • Eguchi, Katsumi;
    • Saito, Kazuyoshi;
    • Okada, Yosuke
    Publication type:
    journal article
    43
    44
    45
    46

    Fifty-Two-Week Results of Clinical and Imaging Assessments of a Patient with Rheumatoid Arthritis Complicated by Systemic Sclerosis with Interstitial Pneumonia and Type 1 Diabetes despite Multiple Disease-Modifying Antirheumatic Drug Therapy That Was Successfully Treated with Baricitinib: A Novel Case Report

    Published in:
    Case Reports in Rheumatology, 2019, p. 1, doi. 10.1155/2019/5293981
    By:
    • Fujita, Yuya;
    • Nawata, Masao;
    • Nagayasu, Atsushi;
    • Someya, Kazuki;
    • Saito, Kazuyoshi;
    • Tanaka, Yoshiya
    Publication type:
    Article
    47
    48
    49
    50